nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—Vinblastine—head and neck cancer	0.125	0.343	CbGbCtD
Posaconazole—ABCB1—Docetaxel—head and neck cancer	0.103	0.282	CbGbCtD
Posaconazole—CYP3A4—Vinblastine—head and neck cancer	0.0748	0.205	CbGbCtD
Posaconazole—CYP3A4—Docetaxel—head and neck cancer	0.0616	0.169	CbGbCtD
Posaconazole—Itraconazole—CYP1A1—head and neck cancer	0.00875	0.625	CrCbGaD
Posaconazole—Ketoconazole—CYP1A1—head and neck cancer	0.00524	0.375	CrCbGaD
Posaconazole—Haemoglobin—Hydroxyurea—head and neck cancer	0.00161	0.00259	CcSEcCtD
Posaconazole—Influenza like illness—Docetaxel—head and neck cancer	0.00161	0.00259	CcSEcCtD
Posaconazole—Haemorrhage—Hydroxyurea—head and neck cancer	0.0016	0.00258	CcSEcCtD
Posaconazole—Candida infection—Docetaxel—head and neck cancer	0.00158	0.00255	CcSEcCtD
Posaconazole—Fluid retention—Docetaxel—head and neck cancer	0.00157	0.00253	CcSEcCtD
Posaconazole—Ataxia—Fluorouracil—head and neck cancer	0.00157	0.00252	CcSEcCtD
Posaconazole—Neuropathy—Docetaxel—head and neck cancer	0.00156	0.0025	CcSEcCtD
Posaconazole—Alopecia—Vinblastine—head and neck cancer	0.00155	0.0025	CcSEcCtD
Posaconazole—Dry skin—Fluorouracil—head and neck cancer	0.00153	0.00246	CcSEcCtD
Posaconazole—Oesophagitis—Docetaxel—head and neck cancer	0.00152	0.00244	CcSEcCtD
Posaconazole—Neoplasm—Docetaxel—head and neck cancer	0.0015	0.00241	CcSEcCtD
Posaconazole—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00149	0.0024	CcSEcCtD
Posaconazole—Muscular weakness—Fluorouracil—head and neck cancer	0.00147	0.00237	CcSEcCtD
Posaconazole—Angiopathy—Hydroxyurea—head and neck cancer	0.00145	0.00234	CcSEcCtD
Posaconazole—Dysphagia—Fluorouracil—head and neck cancer	0.00144	0.00232	CcSEcCtD
Posaconazole—Sepsis—Docetaxel—head and neck cancer	0.00144	0.00232	CcSEcCtD
Posaconazole—Chills—Hydroxyurea—head and neck cancer	0.00144	0.00231	CcSEcCtD
Posaconazole—Eosinophilia—Fluorouracil—head and neck cancer	0.00143	0.0023	CcSEcCtD
Posaconazole—Ill-defined disorder—Vinblastine—head and neck cancer	0.00142	0.00228	CcSEcCtD
Posaconazole—Alopecia—Hydroxyurea—head and neck cancer	0.00142	0.00228	CcSEcCtD
Posaconazole—Anaemia—Vinblastine—head and neck cancer	0.00141	0.00228	CcSEcCtD
Posaconazole—Erythema—Hydroxyurea—head and neck cancer	0.0014	0.00224	CcSEcCtD
Posaconazole—Thrombophlebitis—Docetaxel—head and neck cancer	0.00139	0.00224	CcSEcCtD
Posaconazole—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00138	0.00223	CcSEcCtD
Posaconazole—Malaise—Vinblastine—head and neck cancer	0.00138	0.00222	CcSEcCtD
Posaconazole—Vertigo—Vinblastine—head and neck cancer	0.00138	0.00221	CcSEcCtD
Posaconazole—Leukopenia—Vinblastine—head and neck cancer	0.00137	0.0022	CcSEcCtD
Posaconazole—Pancytopenia—Fluorouracil—head and neck cancer	0.00137	0.0022	CcSEcCtD
Posaconazole—Deafness—Docetaxel—head and neck cancer	0.00135	0.00216	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00134	0.00216	CcSEcCtD
Posaconazole—Hepatic failure—Docetaxel—head and neck cancer	0.00134	0.00215	CcSEcCtD
Posaconazole—Convulsion—Vinblastine—head and neck cancer	0.00133	0.00213	CcSEcCtD
Posaconazole—Hypertension—Vinblastine—head and neck cancer	0.00132	0.00213	CcSEcCtD
Posaconazole—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0013	0.00208	CcSEcCtD
Posaconazole—Pneumonia—Fluorouracil—head and neck cancer	0.00129	0.00208	CcSEcCtD
Posaconazole—Anaemia—Hydroxyurea—head and neck cancer	0.00129	0.00207	CcSEcCtD
Posaconazole—Discomfort—Vinblastine—head and neck cancer	0.00129	0.00207	CcSEcCtD
Posaconazole—Hot flush—Docetaxel—head and neck cancer	0.00129	0.00207	CcSEcCtD
Posaconazole—Infestation NOS—Fluorouracil—head and neck cancer	0.00129	0.00207	CcSEcCtD
Posaconazole—Infestation—Fluorouracil—head and neck cancer	0.00129	0.00207	CcSEcCtD
Posaconazole—Menopausal symptoms—Docetaxel—head and neck cancer	0.00128	0.00205	CcSEcCtD
Posaconazole—Atrial fibrillation—Docetaxel—head and neck cancer	0.00127	0.00204	CcSEcCtD
Posaconazole—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00127	0.00204	CcSEcCtD
Posaconazole—Renal impairment—Docetaxel—head and neck cancer	0.00127	0.00203	CcSEcCtD
Posaconazole—Myocardial infarction—Fluorouracil—head and neck cancer	0.00126	0.00203	CcSEcCtD
Posaconazole—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00126	0.00203	CcSEcCtD
Posaconazole—Malaise—Hydroxyurea—head and neck cancer	0.00126	0.00202	CcSEcCtD
Posaconazole—Stomatitis—Fluorouracil—head and neck cancer	0.00125	0.00202	CcSEcCtD
Posaconazole—Urinary tract infection—Fluorouracil—head and neck cancer	0.00125	0.00201	CcSEcCtD
Posaconazole—Conjunctivitis—Fluorouracil—head and neck cancer	0.00125	0.00201	CcSEcCtD
Posaconazole—Leukopenia—Hydroxyurea—head and neck cancer	0.00125	0.00201	CcSEcCtD
Posaconazole—Cardiac failure—Docetaxel—head and neck cancer	0.00123	0.00198	CcSEcCtD
Posaconazole—Thrombocytopenia—Vinblastine—head and neck cancer	0.00122	0.00197	CcSEcCtD
Posaconazole—Epistaxis—Fluorouracil—head and neck cancer	0.00121	0.00195	CcSEcCtD
Posaconazole—Convulsion—Hydroxyurea—head and neck cancer	0.00121	0.00194	CcSEcCtD
Posaconazole—Hyponatraemia—Docetaxel—head and neck cancer	0.00121	0.00194	CcSEcCtD
Posaconazole—Sinusitis—Fluorouracil—head and neck cancer	0.00121	0.00194	CcSEcCtD
Posaconazole—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.0012	0.00194	CcSEcCtD
Posaconazole—Pain in extremity—Docetaxel—head and neck cancer	0.0012	0.00194	CcSEcCtD
Posaconazole—Agranulocytosis—Fluorouracil—head and neck cancer	0.0012	0.00193	CcSEcCtD
Posaconazole—Anorexia—Vinblastine—head and neck cancer	0.00119	0.00191	CcSEcCtD
Posaconazole—Migraine—Docetaxel—head and neck cancer	0.00119	0.00191	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00118	0.0019	CcSEcCtD
Posaconazole—Discomfort—Hydroxyurea—head and neck cancer	0.00117	0.00189	CcSEcCtD
Posaconazole—Haemoglobin—Fluorouracil—head and neck cancer	0.00116	0.00187	CcSEcCtD
Posaconazole—Rhinitis—Fluorouracil—head and neck cancer	0.00116	0.00186	CcSEcCtD
Posaconazole—Haemorrhage—Fluorouracil—head and neck cancer	0.00115	0.00186	CcSEcCtD
Posaconazole—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00115	0.00185	CcSEcCtD
Posaconazole—Pharyngitis—Fluorouracil—head and neck cancer	0.00115	0.00184	CcSEcCtD
Posaconazole—Oedema—Hydroxyurea—head and neck cancer	0.00114	0.00183	CcSEcCtD
Posaconazole—Ataxia—Docetaxel—head and neck cancer	0.00113	0.00182	CcSEcCtD
Posaconazole—Infection—Hydroxyurea—head and neck cancer	0.00113	0.00182	CcSEcCtD
Posaconazole—Paraesthesia—Vinblastine—head and neck cancer	0.00112	0.0018	CcSEcCtD
Posaconazole—Dehydration—Docetaxel—head and neck cancer	0.00112	0.0018	CcSEcCtD
Posaconazole—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00112	0.0018	CcSEcCtD
Posaconazole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00112	0.00179	CcSEcCtD
Posaconazole—Liver function test abnormal—Docetaxel—head and neck cancer	0.00111	0.00179	CcSEcCtD
Posaconazole—Skin disorder—Hydroxyurea—head and neck cancer	0.00111	0.00178	CcSEcCtD
Posaconazole—Dry skin—Docetaxel—head and neck cancer	0.0011	0.00178	CcSEcCtD
Posaconazole—Abdominal pain upper—Docetaxel—head and neck cancer	0.0011	0.00177	CcSEcCtD
Posaconazole—Orthostatic hypotension—Docetaxel—head and neck cancer	0.0011	0.00177	CcSEcCtD
Posaconazole—Breast disorder—Docetaxel—head and neck cancer	0.00109	0.00175	CcSEcCtD
Posaconazole—Anorexia—Hydroxyurea—head and neck cancer	0.00109	0.00175	CcSEcCtD
Posaconazole—Decreased appetite—Vinblastine—head and neck cancer	0.00109	0.00175	CcSEcCtD
Posaconazole—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00108	0.00174	CcSEcCtD
Posaconazole—Cramp muscle—Docetaxel—head and neck cancer	0.00108	0.00174	CcSEcCtD
Posaconazole—Nasopharyngitis—Docetaxel—head and neck cancer	0.00108	0.00173	CcSEcCtD
Posaconazole—Pain—Vinblastine—head and neck cancer	0.00107	0.00172	CcSEcCtD
Posaconazole—Constipation—Vinblastine—head and neck cancer	0.00107	0.00172	CcSEcCtD
Posaconazole—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00106	0.00171	CcSEcCtD
Posaconazole—Dysphagia—Docetaxel—head and neck cancer	0.00104	0.00167	CcSEcCtD
Posaconazole—Arrhythmia—Fluorouracil—head and neck cancer	0.00103	0.00166	CcSEcCtD
Posaconazole—Feeling abnormal—Vinblastine—head and neck cancer	0.00103	0.00166	CcSEcCtD
Posaconazole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00102	0.00164	CcSEcCtD
Posaconazole—Alopecia—Fluorouracil—head and neck cancer	0.00102	0.00164	CcSEcCtD
Posaconazole—Dyspnoea—Hydroxyurea—head and neck cancer	0.00102	0.00163	CcSEcCtD
Posaconazole—Somnolence—Hydroxyurea—head and neck cancer	0.00101	0.00163	CcSEcCtD
Posaconazole—Erythema—Fluorouracil—head and neck cancer	0.001	0.00162	CcSEcCtD
Posaconazole—Dyspepsia—Hydroxyurea—head and neck cancer	0.001	0.00161	CcSEcCtD
Posaconazole—Decreased appetite—Hydroxyurea—head and neck cancer	0.00099	0.00159	CcSEcCtD
Posaconazole—Pancytopenia—Docetaxel—head and neck cancer	0.000988	0.00159	CcSEcCtD
Posaconazole—Abdominal pain—Vinblastine—head and neck cancer	0.000988	0.00159	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000984	0.00158	CcSEcCtD
Posaconazole—Fatigue—Hydroxyurea—head and neck cancer	0.000982	0.00158	CcSEcCtD
Posaconazole—Pain—Hydroxyurea—head and neck cancer	0.000974	0.00157	CcSEcCtD
Posaconazole—Constipation—Hydroxyurea—head and neck cancer	0.000974	0.00157	CcSEcCtD
Posaconazole—Neutropenia—Docetaxel—head and neck cancer	0.000973	0.00157	CcSEcCtD
Posaconazole—Weight increased—Docetaxel—head and neck cancer	0.000947	0.00152	CcSEcCtD
Posaconazole—Vision blurred—Fluorouracil—head and neck cancer	0.000947	0.00152	CcSEcCtD
Posaconazole—Weight decreased—Docetaxel—head and neck cancer	0.000942	0.00151	CcSEcCtD
Posaconazole—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000939	0.00151	CcSEcCtD
Posaconazole—Pneumonia—Docetaxel—head and neck cancer	0.000933	0.0015	CcSEcCtD
Posaconazole—Anaemia—Fluorouracil—head and neck cancer	0.000929	0.00149	CcSEcCtD
Posaconazole—Infestation NOS—Docetaxel—head and neck cancer	0.000928	0.00149	CcSEcCtD
Posaconazole—Infestation—Docetaxel—head and neck cancer	0.000928	0.00149	CcSEcCtD
Posaconazole—Hypersensitivity—Vinblastine—head and neck cancer	0.00092	0.00148	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00092	0.00148	CcSEcCtD
Posaconazole—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000915	0.00147	CcSEcCtD
Posaconazole—Renal failure—Docetaxel—head and neck cancer	0.000912	0.00147	CcSEcCtD
Posaconazole—Myocardial infarction—Docetaxel—head and neck cancer	0.00091	0.00146	CcSEcCtD
Posaconazole—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00091	0.00146	CcSEcCtD
Posaconazole—Jaundice—Docetaxel—head and neck cancer	0.000905	0.00145	CcSEcCtD
Posaconazole—Stomatitis—Docetaxel—head and neck cancer	0.000905	0.00145	CcSEcCtD
Posaconazole—Conjunctivitis—Docetaxel—head and neck cancer	0.000902	0.00145	CcSEcCtD
Posaconazole—Body temperature increased—Hydroxyurea—head and neck cancer	0.000901	0.00145	CcSEcCtD
Posaconazole—Leukopenia—Fluorouracil—head and neck cancer	0.000899	0.00145	CcSEcCtD
Posaconazole—Asthenia—Vinblastine—head and neck cancer	0.000896	0.00144	CcSEcCtD
Posaconazole—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000878	0.00141	CcSEcCtD
Posaconazole—Epistaxis—Docetaxel—head and neck cancer	0.000875	0.00141	CcSEcCtD
Posaconazole—Convulsion—Fluorouracil—head and neck cancer	0.000871	0.0014	CcSEcCtD
Posaconazole—Agranulocytosis—Docetaxel—head and neck cancer	0.000866	0.00139	CcSEcCtD
Posaconazole—Chest pain—Fluorouracil—head and neck cancer	0.000855	0.00138	CcSEcCtD
Posaconazole—Myalgia—Fluorouracil—head and neck cancer	0.000855	0.00138	CcSEcCtD
Posaconazole—Diarrhoea—Vinblastine—head and neck cancer	0.000855	0.00137	CcSEcCtD
Posaconazole—Discomfort—Fluorouracil—head and neck cancer	0.000845	0.00136	CcSEcCtD
Posaconazole—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000839	0.00135	CcSEcCtD
Posaconazole—Haemoglobin—Docetaxel—head and neck cancer	0.000837	0.00135	CcSEcCtD
Posaconazole—Rhinitis—Docetaxel—head and neck cancer	0.000835	0.00134	CcSEcCtD
Posaconazole—Haemorrhage—Docetaxel—head and neck cancer	0.000833	0.00134	CcSEcCtD
Posaconazole—Hepatitis—Docetaxel—head and neck cancer	0.000833	0.00134	CcSEcCtD
Posaconazole—Hypoaesthesia—Docetaxel—head and neck cancer	0.000829	0.00133	CcSEcCtD
Posaconazole—Confusional state—Fluorouracil—head and neck cancer	0.000827	0.00133	CcSEcCtD
Posaconazole—Pharyngitis—Docetaxel—head and neck cancer	0.000827	0.00133	CcSEcCtD
Posaconazole—Dizziness—Vinblastine—head and neck cancer	0.000826	0.00133	CcSEcCtD
Posaconazole—Urinary tract disorder—Docetaxel—head and neck cancer	0.000823	0.00132	CcSEcCtD
Posaconazole—Oedema peripheral—Docetaxel—head and neck cancer	0.000821	0.00132	CcSEcCtD
Posaconazole—Oedema—Fluorouracil—head and neck cancer	0.00082	0.00132	CcSEcCtD
Posaconazole—Connective tissue disorder—Docetaxel—head and neck cancer	0.000819	0.00132	CcSEcCtD
Posaconazole—Asthenia—Hydroxyurea—head and neck cancer	0.000817	0.00131	CcSEcCtD
Posaconazole—Urethral disorder—Docetaxel—head and neck cancer	0.000817	0.00131	CcSEcCtD
Posaconazole—Infection—Fluorouracil—head and neck cancer	0.000815	0.00131	CcSEcCtD
Posaconazole—Nervous system disorder—Fluorouracil—head and neck cancer	0.000804	0.00129	CcSEcCtD
Posaconazole—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000803	0.00129	CcSEcCtD
Posaconazole—Tachycardia—Fluorouracil—head and neck cancer	0.0008	0.00129	CcSEcCtD
Posaconazole—Vomiting—Vinblastine—head and neck cancer	0.000794	0.00128	CcSEcCtD
Posaconazole—Erythema multiforme—Docetaxel—head and neck cancer	0.000788	0.00127	CcSEcCtD
Posaconazole—Headache—Vinblastine—head and neck cancer	0.000783	0.00126	CcSEcCtD
Posaconazole—Anorexia—Fluorouracil—head and neck cancer	0.000782	0.00126	CcSEcCtD
Posaconazole—Diarrhoea—Hydroxyurea—head and neck cancer	0.000779	0.00125	CcSEcCtD
Posaconazole—Eye disorder—Docetaxel—head and neck cancer	0.000779	0.00125	CcSEcCtD
Posaconazole—Cardiac disorder—Docetaxel—head and neck cancer	0.000773	0.00124	CcSEcCtD
Posaconazole—Flushing—Docetaxel—head and neck cancer	0.000773	0.00124	CcSEcCtD
Posaconazole—Hypotension—Fluorouracil—head and neck cancer	0.000766	0.00123	CcSEcCtD
Posaconazole—Angiopathy—Docetaxel—head and neck cancer	0.000756	0.00122	CcSEcCtD
Posaconazole—Dizziness—Hydroxyurea—head and neck cancer	0.000753	0.00121	CcSEcCtD
Posaconazole—Immune system disorder—Docetaxel—head and neck cancer	0.000752	0.00121	CcSEcCtD
Posaconazole—Mediastinal disorder—Docetaxel—head and neck cancer	0.000751	0.00121	CcSEcCtD
Posaconazole—Chills—Docetaxel—head and neck cancer	0.000747	0.0012	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000747	0.0012	CcSEcCtD
Posaconazole—Arrhythmia—Docetaxel—head and neck cancer	0.000744	0.0012	CcSEcCtD
Posaconazole—Nausea—Vinblastine—head and neck cancer	0.000742	0.00119	CcSEcCtD
Posaconazole—Insomnia—Fluorouracil—head and neck cancer	0.000742	0.00119	CcSEcCtD
Posaconazole—Paraesthesia—Fluorouracil—head and neck cancer	0.000736	0.00118	CcSEcCtD
Posaconazole—Alopecia—Docetaxel—head and neck cancer	0.000736	0.00118	CcSEcCtD
Posaconazole—Dyspnoea—Fluorouracil—head and neck cancer	0.000731	0.00118	CcSEcCtD
Posaconazole—Mental disorder—Docetaxel—head and neck cancer	0.00073	0.00117	CcSEcCtD
Posaconazole—Somnolence—Fluorouracil—head and neck cancer	0.000729	0.00117	CcSEcCtD
Posaconazole—Erythema—Docetaxel—head and neck cancer	0.000725	0.00117	CcSEcCtD
Posaconazole—Malnutrition—Docetaxel—head and neck cancer	0.000725	0.00117	CcSEcCtD
Posaconazole—Vomiting—Hydroxyurea—head and neck cancer	0.000724	0.00116	CcSEcCtD
Posaconazole—Dyspepsia—Fluorouracil—head and neck cancer	0.000722	0.00116	CcSEcCtD
Posaconazole—Rash—Hydroxyurea—head and neck cancer	0.000718	0.00116	CcSEcCtD
Posaconazole—Dermatitis—Hydroxyurea—head and neck cancer	0.000718	0.00115	CcSEcCtD
Posaconazole—Headache—Hydroxyurea—head and neck cancer	0.000714	0.00115	CcSEcCtD
Posaconazole—Decreased appetite—Fluorouracil—head and neck cancer	0.000713	0.00115	CcSEcCtD
Posaconazole—Dysgeusia—Docetaxel—head and neck cancer	0.00071	0.00114	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000708	0.00114	CcSEcCtD
Posaconazole—Back pain—Docetaxel—head and neck cancer	0.000701	0.00113	CcSEcCtD
Posaconazole—Pain—Fluorouracil—head and neck cancer	0.000701	0.00113	CcSEcCtD
Posaconazole—Muscle spasms—Docetaxel—head and neck cancer	0.000697	0.00112	CcSEcCtD
Posaconazole—Nausea—Hydroxyurea—head and neck cancer	0.000677	0.00109	CcSEcCtD
Posaconazole—Feeling abnormal—Fluorouracil—head and neck cancer	0.000676	0.00109	CcSEcCtD
Posaconazole—Anaemia—Docetaxel—head and neck cancer	0.00067	0.00108	CcSEcCtD
Posaconazole—Urticaria—Fluorouracil—head and neck cancer	0.000651	0.00105	CcSEcCtD
Posaconazole—Syncope—Docetaxel—head and neck cancer	0.00065	0.00105	CcSEcCtD
Posaconazole—Leukopenia—Docetaxel—head and neck cancer	0.000649	0.00104	CcSEcCtD
Posaconazole—Body temperature increased—Fluorouracil—head and neck cancer	0.000648	0.00104	CcSEcCtD
Posaconazole—Loss of consciousness—Docetaxel—head and neck cancer	0.000637	0.00103	CcSEcCtD
Posaconazole—Cough—Docetaxel—head and neck cancer	0.000633	0.00102	CcSEcCtD
Posaconazole—Convulsion—Docetaxel—head and neck cancer	0.000628	0.00101	CcSEcCtD
Posaconazole—Hypertension—Docetaxel—head and neck cancer	0.000626	0.00101	CcSEcCtD
Posaconazole—Arthralgia—Docetaxel—head and neck cancer	0.000617	0.000993	CcSEcCtD
Posaconazole—Chest pain—Docetaxel—head and neck cancer	0.000617	0.000993	CcSEcCtD
Posaconazole—Myalgia—Docetaxel—head and neck cancer	0.000617	0.000993	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000613	0.000986	CcSEcCtD
Posaconazole—Hypersensitivity—Fluorouracil—head and neck cancer	0.000604	0.000972	CcSEcCtD
Posaconazole—Dry mouth—Docetaxel—head and neck cancer	0.000604	0.000971	CcSEcCtD
Posaconazole—Confusional state—Docetaxel—head and neck cancer	0.000597	0.00096	CcSEcCtD
Posaconazole—Oedema—Docetaxel—head and neck cancer	0.000592	0.000952	CcSEcCtD
Posaconazole—Infection—Docetaxel—head and neck cancer	0.000588	0.000946	CcSEcCtD
Posaconazole—Shock—Docetaxel—head and neck cancer	0.000582	0.000936	CcSEcCtD
Posaconazole—Nervous system disorder—Docetaxel—head and neck cancer	0.00058	0.000933	CcSEcCtD
Posaconazole—Pruritus—Fluorouracil—head and neck cancer	0.00058	0.000933	CcSEcCtD
Posaconazole—Thrombocytopenia—Docetaxel—head and neck cancer	0.000579	0.000932	CcSEcCtD
Posaconazole—Tachycardia—Docetaxel—head and neck cancer	0.000578	0.000929	CcSEcCtD
Posaconazole—Skin disorder—Docetaxel—head and neck cancer	0.000575	0.000925	CcSEcCtD
Posaconazole—Anorexia—Docetaxel—head and neck cancer	0.000564	0.000907	CcSEcCtD
Posaconazole—Diarrhoea—Fluorouracil—head and neck cancer	0.000561	0.000902	CcSEcCtD
Posaconazole—Hypotension—Docetaxel—head and neck cancer	0.000553	0.000889	CcSEcCtD
Posaconazole—Dizziness—Fluorouracil—head and neck cancer	0.000542	0.000872	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000539	0.000867	CcSEcCtD
Posaconazole—Insomnia—Docetaxel—head and neck cancer	0.000535	0.000861	CcSEcCtD
Posaconazole—Paraesthesia—Docetaxel—head and neck cancer	0.000531	0.000855	CcSEcCtD
Posaconazole—Dyspnoea—Docetaxel—head and neck cancer	0.000528	0.000849	CcSEcCtD
Posaconazole—Somnolence—Docetaxel—head and neck cancer	0.000526	0.000846	CcSEcCtD
Posaconazole—Vomiting—Fluorouracil—head and neck cancer	0.000521	0.000838	CcSEcCtD
Posaconazole—Dyspepsia—Docetaxel—head and neck cancer	0.000521	0.000838	CcSEcCtD
Posaconazole—Rash—Fluorouracil—head and neck cancer	0.000517	0.000831	CcSEcCtD
Posaconazole—Dermatitis—Fluorouracil—head and neck cancer	0.000517	0.000831	CcSEcCtD
Posaconazole—Decreased appetite—Docetaxel—head and neck cancer	0.000515	0.000827	CcSEcCtD
Posaconazole—Headache—Fluorouracil—head and neck cancer	0.000514	0.000826	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000511	0.000822	CcSEcCtD
Posaconazole—Fatigue—Docetaxel—head and neck cancer	0.00051	0.000821	CcSEcCtD
Posaconazole—Pain—Docetaxel—head and neck cancer	0.000506	0.000814	CcSEcCtD
Posaconazole—Constipation—Docetaxel—head and neck cancer	0.000506	0.000814	CcSEcCtD
Posaconazole—Feeling abnormal—Docetaxel—head and neck cancer	0.000488	0.000784	CcSEcCtD
Posaconazole—Nausea—Fluorouracil—head and neck cancer	0.000487	0.000783	CcSEcCtD
Posaconazole—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000484	0.000778	CcSEcCtD
Posaconazole—Abdominal pain—Docetaxel—head and neck cancer	0.000468	0.000752	CcSEcCtD
Posaconazole—Body temperature increased—Docetaxel—head and neck cancer	0.000468	0.000752	CcSEcCtD
Posaconazole—Hypersensitivity—Docetaxel—head and neck cancer	0.000436	0.000701	CcSEcCtD
Posaconazole—Asthenia—Docetaxel—head and neck cancer	0.000425	0.000683	CcSEcCtD
Posaconazole—Pruritus—Docetaxel—head and neck cancer	0.000419	0.000673	CcSEcCtD
Posaconazole—Diarrhoea—Docetaxel—head and neck cancer	0.000405	0.000651	CcSEcCtD
Posaconazole—Dizziness—Docetaxel—head and neck cancer	0.000391	0.000629	CcSEcCtD
Posaconazole—Vomiting—Docetaxel—head and neck cancer	0.000376	0.000605	CcSEcCtD
Posaconazole—Rash—Docetaxel—head and neck cancer	0.000373	0.0006	CcSEcCtD
Posaconazole—Dermatitis—Docetaxel—head and neck cancer	0.000373	0.0006	CcSEcCtD
Posaconazole—Headache—Docetaxel—head and neck cancer	0.000371	0.000596	CcSEcCtD
Posaconazole—Nausea—Docetaxel—head and neck cancer	0.000352	0.000565	CcSEcCtD
